Home/Structure Therapeutics/Wei (Wayne) Wang, Ph.D.
W(

Wei (Wayne) Wang, Ph.D.

Chief Executive Officer

Structure Therapeutics

Structure Therapeutics Pipeline

DrugIndicationPhase
GSBR-1290ObesityPhase 2
ANPA-0073Pulmonary Arterial Hypertension (PAH)Preclinical
LTSE-2578ObesityPreclinical